Ataraxis AI
PrivateLast Round
Early Funding
Apr 21, 2025
Est. Valuation
$68.4M
Total Funding Raised
$48.8M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Ataraxis AI is a precision oncology company that develops AI-powered diagnostic tools to personalize cancer treatment selection and prognosis.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ataraxis AI Comparables
Compare Ataraxis AI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Clairity, Inc. | 88% | |
| PreciseDx | 87% | |
| ScreenPoint Medical | 82% |
Ataraxis AI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 21, 2025 | ||||
| Series A | Mar 5, 2025 | ||||
| Seed | Oct 31, 2024 |
Key People
Founding team and executive leadership
Ataraxis AI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bertelsmann Investments | Series A |
| Floating Point | Series A |
| Founders Fund | Series A |
| Floating Point Advisors | Series A |
| Thiel Bio | Series A |
| Obvious Ventures | Series A, Seed |
| AIX Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
Grew 18% QoQ, from 40 to 47 employees.
- Mar 30, 2026
Ataraxis Breast CTX estimates individualized chemotherapy benefits for patients.
Recent news
Latest coverage and updates
- launchesSep 18, 2026
Ataraxis launches models for cancer treatment prediction.
- launchesSep 18, 2026
Ataraxis launches generation of models.
Ataraxis AI Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ataraxis AI's valuation, stock price, and market status.
Is Ataraxis AI a public or private company?
Ataraxis AI is a private company.
What is the current stock price of Ataraxis AI?
Ataraxis AI is a private company with no public stock price. No recent secondary market data is available.
How much is Ataraxis AI worth (valuation)?
Ataraxis AI's valuation is estimated at $68.4M based on funding round data.
Can I buy Ataraxis AI stock?
Ataraxis AI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ataraxis AI's last funding round?
Ataraxis AI's most recent funding round was Early Funding on March 5, 2025.
Who are the main investors in Ataraxis AI?
Key investors in Ataraxis AI include Obvious Ventures, AIX Ventures, Giant Ventures.
Will Ataraxis AI IPO soon?
No public IPO plans have been announced for Ataraxis AI.
How can I track Ataraxis AI secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ataraxis AI's secondary market activity and sign up for updates.